BSE filing, NSE: PHOTON. Summary written from the filing by ALFA Finder's alert engine.
Photon Capital Advisors Ltd: key numbers
- Share price
- ₹553.65
- Market cap
- ₹150.6 Cr
- Revenue (annual)
- ₹1.44 Cr
- Net profit (annual)
- ₹0.89 Cr
- P/E (TTM)
- 130.8×Sector 19.8×
- Promoter holding
- 54.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Photon Capital Advisors Ltd
All →Photon Capital Advisors Other Announcement
Photon Capital Advisors Ltd. submitted the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Photon Capital Advisors Management Change
Photon Capital Advisors Ltd. has appointed Mr. Rama Kiran Kumar Varma Pothuri as the new Chief Financial Officer (CFO), effective September 29, 2026.
Photon Capital Advisors Annual General Meeting
Photon Capital Advisors Ltd held its 41st Annual General Meeting on September 21, 2026. The meeting discussed various business items including director appointments and ESOS adoption.
Photon Capital Advisors Annual General Meeting
Photon Capital Advisors Ltd. submitted its 41st Annual General Meeting notice and Annual Report for FY 2025-26. The meeting is scheduled for September 21, 2026.
Photon Capital Advisors Management Change
Photon Capital Advisors Limited appointed Mr. Navneeth Subramanian as an Independent Director and Mrs. P V Lakshmi Rajani as Secretarial Auditor.
Photon Capital Advisors Q1 FY27 Results: Turns Profitable, Net Profit ₹0.2 Cr
Photon Capital Advisors Ltd reported revenue from operations of ₹0.2 Cr and net profit of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr